Literature DB >> 26649872

Author's Reply to Zheng et al.: A Physiologically Based Pharmacokinetic Drug-Disease Model to Predict Carvedilol Exposure in Adult and Paediatric Heart Failure Patients by Incorporating Pathophysiological Changes in Hepatic and Renal Blood Flows.

Muhammad Fawad Rasool1,2, Feras Khalil3, Stephanie Läer3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26649872     DOI： 10.1007/s40262-015-0349-0

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN： 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  6 in total

1.  Steady-state pharmacokinetics of carvedilol and its enantiomers in patients with congestive heart failure.

Authors:  D Tenero; S Boike; D Boyle; B Ilson; H F Fesniak; S Brozena; D Jorkasky
Journal:  J Clin Pharmacol       Date:  2000-08       Impact factor: 3.126

2.  Physiologic pharmacokinetic modeling of gastrointestinal blood flow as a rate-limiting step in the oral absorption of digoxin: implications for patients with congestive heart failure receiving epoprostenol.

Authors:  L D Carlton; G M Pollack; K L Brouwer
Journal:  J Pharm Sci       Date:  1996-05       Impact factor: 3.534

3.  Regional blood flow in chronic heart failure: the reason for the lack of correlation between patients' exercise tolerance and cardiac output?

Authors:  A F Muller; P Batin; S Evans; M Hawkins; A J Cowley
Journal:  Br Heart J       Date:  1992-06

4.  Assessment of Age-Related Changes in Pediatric Gastrointestinal Solubility.

Authors:  Anil R Maharaj; Andrea N Edginton; Nikoletta Fotaki
Journal:  Pharm Res       Date:  2015-07-29       Impact factor: 4.200

5.  Intestinal blood flow in patients with chronic heart failure: a link with bacterial growth, gastrointestinal symptoms, and cachexia.

Authors:  Anja Sandek; Alexander Swidsinski; Wieland Schroedl; Alastair Watson; Miroslava Valentova; Ralph Herrmann; Nadja Scherbakov; Larissa Cramer; Mathias Rauchhaus; Anke Grosse-Herrenthey; Monika Krueger; Stephan von Haehling; Wolfram Doehner; Stefan D Anker; Juergen Bauditz
Journal:  J Am Coll Cardiol       Date:  2014-09-16       Impact factor: 24.094

6.  A physiologically based pharmacokinetic drug-disease model to predict carvedilol exposure in adult and paediatric heart failure patients by incorporating pathophysiological changes in hepatic and renal blood flows.

Authors:  Muhammad Fawad Rasool; Feras Khalil; Stephanie Läer
Journal:  Clin Pharmacokinet       Date:  2015-09       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.